[Long term treatment of acromegaly with bromoergocryptine (CB-154)]. 1980

A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
December 1977, Horumon to rinsho. Clinical endocrinology,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
July 1977, Archiv fur Gynakologie,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
December 1977, Horumon to rinsho. Clinical endocrinology,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
December 1977, Horumon to rinsho. Clinical endocrinology,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
December 1977, Horumon to rinsho. Clinical endocrinology,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
December 1977, Horumon to rinsho. Clinical endocrinology,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
June 1979, Minerva ginecologica,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
December 1977, Horumon to rinsho. Clinical endocrinology,
A Bonetti, and J L Del Arbol, and M E Ruíz Requena, and A Diez Ruíz, and B Gil Extremera, and A Peña Yáñez
December 1977, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!